Home » Medicines Company Receives European Approval for Angiox
Medicines Company Receives European Approval for Angiox
The Medicines Company announced Tuesday that it has received European approval
for the use of Angiox (bivalirudin) as an anticoagulant in patients with heart attacks … undergoing emergency heart procedures called primary percutaneous
coronary intervention.
CNNMoney
CNNMoney
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May